We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.06%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$2.66B
AUM Growth
+$447M
Cap. Flow
+$395M
Cap. Flow %
14.87%
Top 10 Hldgs %
18.05%
Holding
1,302
New
172
Increased
969
Reduced
51
Closed
109

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$18.9M
2
MSFT icon
Microsoft
MSFT
+$13.5M
3
AAPL icon
Apple
AAPL
+$12.1M
4
XOM icon
ExxonMobil
XOM
+$7.45M
5
META icon
Meta Platforms (Facebook)
META
+$7.29M

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Healthcare 13.73%
3 Consumer Discretionary 11.89%
4 Financials 11.87%
5 Industrials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
151
Morgan Stanley
MS
$337B
$3.31M 0.12%
71,085
+7,663
+12% +$374K
ZBRA icon
152
Zebra Technologies
ZBRA
$12.4B
$3.29M 0.12%
18,591
+1,697
+10% +$272K
ADI icon
153
Analog Devices
ADI
$181B
$3.27M 0.12%
35,394
+6,309
+22% +$606K
TYL icon
154
Tyler Technologies
TYL
$12.2B
$3.26M 0.12%
13,290
+2,029
+18% +$483K
ADSK icon
155
Autodesk
ADSK
$44.3B
$3.25M 0.12%
20,814
+3,460
+20% +$489K
VLO icon
156
Valero Energy
VLO
$89.8B
$3.23M 0.12%
28,366
+8,636
+44% +$981K
FISV
157
Fiserv Inc
FISV
$27.2B
$3.21M 0.12%
39,004
+6,266
+19% +$492K
SCHW
158
Charles Schwab
SCHW
$177B
$3.17M 0.12%
64,476
+7,785
+14% +$398K
MOH icon
159
Molina Healthcare
MOH
$10.3B
$3.15M 0.12%
21,207
+6,184
+41% +$789K
WST icon
160
West Pharmaceutical
WST
$23.1B
$3.15M 0.12%
25,476
+2,201
+9% +$247K
FDX icon
161
FedEx
FDX
$74.5B
$3.14M 0.12%
13,046
+1,301
+11% +$315K
RTN
162
DELISTED
Raytheon Company
RTN
$3.14M 0.12%
15,201
+1,836
+14% +$365K
CL icon
163
Colgate-Palmolive
CL
$72.6B
$3.13M 0.12%
46,771
+6,194
+15% +$413K
ALXN
164
DELISTED
Alexion Pharmaceuticals
ALXN
$3.13M 0.12%
22,495
+4,994
+29% +$626K
BLK icon
165
Blackrock
BLK
$164B
$3.11M 0.12%
6,600
+816
+14% +$397K
VMW
166
DELISTED
VMware, Inc
VMW
$3.09M 0.12%
+19,828
New +$3.03M
WAB icon
167
Wabtec
WAB
$51.1B
$3.09M 0.12%
29,452
+2,343
+9% +$253K
GD icon
168
General Dynamics
GD
$105B
$3.06M 0.12%
14,931
+2,203
+17% +$431K
DUK icon
169
Duke Energy
DUK
$102B
$3.06M 0.12%
38,191
+5,865
+18% +$474K
CME icon
170
CME Group
CME
$92.2B
$3.04M 0.11%
17,839
+2,228
+14% +$375K
TDY icon
171
Teledyne Technologies
TDY
$30.4B
$3.03M 0.11%
12,300
+984
+9% +$224K
SYK icon
172
Stryker
SYK
$127B
$3.01M 0.11%
16,945
+2,150
+15% +$367K
EWBC icon
173
East-West Bancorp
EWBC
$17.9B
$3M 0.11%
49,755
+3,919
+9% +$252K
NOK icon
174
Nokia
NOK
$50.8B
$2.99M 0.11%
535,349
+20,384
+4% +$113K
CPT icon
175
Camden Property Trust
CPT
$11.3B
$2.98M 0.11%
31,842
+2,498
+9% +$232K

Similar funds

Pacer Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Pacer Advisors held 1,302 positions worth $2.66B, up 20% from $2.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Pacer Advisors deployed $395M of net new capital in Q3 2018, opening 172 new positions and adding to 969 existing holdings. Its largest new stake was VMware, Inc: 19,828 shares worth $3.09M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $3.26M trimmed.

  • Pacer Advisors's largest Q3 2018 buy was VMware, Inc: 19,828 shares worth $3.09M.
  • Pacer Advisors added most to Amazon in Q3 2018, an estimated $18.9M increase.
  • Pacer Advisors's biggest Q3 2018 reduction was Wellcare Health Plans, Inc., cutting an estimated $3.26M.
  • Pacer Advisors fully exited BASF AKTIENGESELLT ADS(RP1 ORD in Q3 2018, selling an estimated $7.2M.
  • Pacer Advisors's ten largest holdings make up 18% of its $2.66B portfolio in Q3 2018.
  • Pacer Advisors opened 172 new positions and closed 109 in Q3 2018.
  • Pacer Advisors's portfolio value rose 20% quarter-over-quarter to $2.66B.

Based on Pacer Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.